Terms: = Bone cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
12 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of a novel NAD
Yu R; Lu G; Cheng B; Li J; Jiang Q; Lan X
J Orthop Res; 2024 May; 42(5):1086-1103. PubMed ID: 38047487
[TBL] [Abstract] [Full Text] [Related]
3. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
4. bone mesenchymal stem cells promote gastric cancer progression through TGF-β1/smad2 positive feedback loop.
Fan M; Zhang Y; Shi H; Xiang L; Yao H; Lin R
Life Sci; 2023 Jun; 323():121657. PubMed ID: 37019301
[TBL] [Abstract] [Full Text] [Related]
5. Recent progress in the biology and physiology of BMP-8a.
Tang J; Tan M; Liao S; Pang M; Li J
Connect Tissue Res; 2023 May; 64(3):219-228. PubMed ID: 36594156
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of TGFβ improves hematopoietic stem cell niche and ameliorates cancer-related anemia.
Wang B; Wang Y; Chen H; Yao S; Lai X; Qiu Y; Cai J; Huang Y; Wei X; Guan Y; Wang T; Wang J; Xiang AP
Stem Cell Res Ther; 2021 Jan; 12(1):65. PubMed ID: 33461597
[TBL] [Abstract] [Full Text] [Related]
7. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
[TBL] [Abstract] [Full Text] [Related]
9. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract] [Full Text] [Related]
10. Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis.
Zandueta C; Ormazábal C; Perurena N; Martínez-Canarias S; Zalacaín M; Julián MS; Grigoriadis AE; Valencia K; Campos-Laborie FJ; Rivas Jde L; Vicent S; Patiño-García A; Lecanda F
J Pathol; 2016 Aug; 239(4):438-49. PubMed ID: 27172275
[TBL] [Abstract] [Full Text] [Related]
11. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.
Peng J; Yoshioka Y; Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Kharma B; Murakami R; Abiko K; Murphy SK; Konishi I
Mol Carcinog; 2016 Apr; 55(4):335-45. PubMed ID: 25663289
[TBL] [Abstract] [Full Text] [Related]
12. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
[TBL] [Abstract] [Full Text] [Related]
